{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:59:53Z","timestamp":1792634393120,"version":"4.5.0"},"reference-count":53,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["OncoImmunology"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/2162402x.2022.2156091","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T05:02:18Z","timestamp":1671080538000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibition"],"prefix":"10.1080","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-4459","authenticated-orcid":false,"given":"Julia","family":"Koerner","sequence":"first","affiliation":[{"name":"University of Konstanz","place":["Konstanz, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9310-536X","authenticated-orcid":false,"given":"Dennis","family":"Horvath","sequence":"additional","affiliation":[{"name":"University of Konstanz","place":["Konstanz, Germany"]},{"name":"University of Konstanz","place":["Konstanz, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3280-448X","authenticated-orcid":false,"given":"Franziska","family":"Oliveri","sequence":"additional","affiliation":[{"name":"University of Konstanz","place":["Konstanz, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0891-4328","authenticated-orcid":false,"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Chongqing University Cancer Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9428-2349","authenticated-orcid":false,"given":"Michael","family":"Basler","sequence":"additional","affiliation":[{"name":"University of Konstanz","place":["Konstanz, Germany"]},{"name":"Biotechnology Institute Thurgau (BITg) at the University of Konstanz","place":["Kreuzlingen, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0267-9"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2017.167"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22805"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23343"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-5164"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24497"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00090-14"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu587"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0266-0"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.04.023"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1978"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2687"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201303543"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903182"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900182"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201846512"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15141"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14579"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.03.018"},{"key":"e_1_3_6_21_1","first-page":"4096","article-title":"Metastatic prostate cancer in a transgenic mouse","volume":"56","author":"Gingrich JR","year":"1996","unstructured":"Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, et al. Metastatic prostate cancer in a transgenic mouse. Cancer Res. 1996;56:4096\u20134102.","journal-title":"Cancer Res"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8066463"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.8.3439"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(98)00204-X"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/0192623311425062"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.20123"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.10.022"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.10215"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-3145"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.191"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09804.x"},{"key":"e_1_3_6_32_1","first-page":"4687","article-title":"Androgen-independent prostate cancer progression in the TRAMP model","volume":"57","author":"Gingrich JR","year":"1997","unstructured":"Gingrich JR, Barrios RJ, Kattan MW, Nahm HS, Finegold MJ, Greenberg NM. Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res. 1997;57:4687\u20134691.","journal-title":"Cancer Res"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.070602"},{"key":"e_1_3_6_34_1","first-page":"S74","article-title":"The immunoproteasome: a novel drug target for autoimmune diseases","volume":"33","author":"Basler M","year":"2015","unstructured":"Basler M, Mundt S, Bitzer A, Schmidt C, Groettrup M. The immunoproteasome: a novel drug target for autoimmune diseases. Clin Exp Rheumatol. 2015;33:S74\u201379.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_6_35_1","first-page":"Abstract 2587","volume-title":"KZR-616, a Selective Inhibitor of the Immunoproteasome, shows a promising safety and target inhibition profile in a phase I, double-blind, single (SAD) and multiple ascending dose (MAD) study in healthy volunteers arthritis rheumatol","author":"Lickliter J","year":"2017","unstructured":"Lickliter J, Anderl J, Kirk CJ, Wang J, Bomba D. KZR-616, a Selective Inhibitor of the Immunoproteasome, shows a promising safety and target inhibition profile in a phase I, double-blind, single (SAD) and multiple ascending dose (MAD) study in healthy volunteers arthritis rheumatol. 2017;Vol. 69 suppl 10:Abstract 2587."},{"key":"e_1_3_6_36_1","first-page":"1357","article-title":"The proteasome inhibitor, bortezomib, induces prostate cancer cell death by suppressing the expression of prostate-specific membrane antigen, as well as androgen receptor","volume":"54","author":"Kuroda K","year":"2019","unstructured":"Kuroda K, Liu H. The proteasome inhibitor, bortezomib, induces prostate cancer cell death by suppressing the expression of prostate-specific membrane antigen, as well as androgen receptor. Int JOncol. 2019;54:1357\u20131366.","journal-title":"Int JOncol"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1735"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.02.106"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.243"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-009-0679-1"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001517"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3976"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.5114\/pjp.2020.95415"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-014-0031-3"},{"key":"e_1_3_6_45_1","first-page":"3181","article-title":"Increased circulating myeloid-derived suppressor cells correlate with cancer stages, interleukin-8 and \u22126 in prostate cancer","volume":"7","author":"Chi N","year":"2014","unstructured":"Chi N, Tan Z, Ma K, Bao L, Yun Z. Increased circulating myeloid-derived suppressor cells correlate with cancer stages, interleukin-8 and \u22126 in prostate cancer. Int J Clin Exp Med. 2014;7:3181\u20133192.","journal-title":"Int J Clin Exp Med"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.4RU0819-150RR"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature21676"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-2422"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0106"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902574"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1902651116"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.240"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040720"}],"container-title":["OncoImmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/2162402X.2022.2156091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:42:33Z","timestamp":1780418553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/2162402X.2022.2156091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/2162402X.2022.2156091"],"URL":"https:\/\/doi.org\/10.1080\/2162402x.2022.2156091","relation":{},"ISSN":["2162-402X"],"issn-type":[{"value":"2162-402X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-02-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2156091"}}